Last updated: June 5, 2026

Back to directory

Kheiron Mia medical AI product profile

Kheiron's Mia platform supports breast-screening workflows, including Mia Triage for double-reader triage and Mia IQ for image-quality assurance.

Screenshot of the official Kheiron Mia product page
Medical imaging and radiology

Best fit

Screening programs evaluating AI as a governed support layer for double-reading capacity, quality assurance, and pathway efficiency.

Primary use case
AI-supported breast screening triage, reader workflow support, image-quality review, and mammography pathway optimization
Audience
Breast screening programs, radiology providers, NHS and international screening services, and breast imaging governance teams
Risk level
High
Pricing signal
Enterprise and market-specific pricing; verify local registration, distributor path, supported modules, and implementation terms.
Official sources
5 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Kheiron Mia as safe for a local clinical, operational, or research workflow.

Regulatory / FDAReview each module separately because Mia Triage, Mia Reader, Mia IQ, and RSViP may have different intended uses and country-specific authorization paths.
PrivacyAssess mammography image flow, patient identifiers, PACS/RIS integration, cloud or distributor processing, retention, access controls, audit logs, and data-processing terms.
EvidenceRequire local screening-program evidence for detection, recall, workload, image quality, population fit, scanner mix, and post-market monitoring rather than relying only on headline performance claims.
WorkflowBest governed as pathway support for radiologist-reviewed screening, with explicit rules for triage thresholds, quality-audit actions, second-reader escalation, and patient-safety review.

Where Kheiron Mia fits

Kheiron describes Mia as a breast screening AI platform with Mia Triage for double-reading triage and Mia IQ for image-quality assurance; product pages state CE/UK status for Mia, TGA and Medsafe clearance for Mia, and FDA registration for Mia IQ in the United States.

Not for: U.S. diagnostic mammography claims without product-specific FDA review, autonomous recall decisions, or assuming Mia Triage and Mia IQ have identical regulatory status.

What to verify before using Kheiron Mia

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products